Training needs | Ranking | ||||
Very important | Quite important | Important | Not important | Total institutions* | |
Scientific design issues in intervention trials | 27 | 2 | 29 | ||
Determination of potential risks of malaria vaccine research | 25 | 3 | 1 | 29 | |
Determinations to run phases (I,II,III) in a country or community | 25 | 2 | 1 | 28 | |
Monitoring and oversight | 23 | 5 | 1 | 29 | |
Post-trial access to benefits (eg, successful intervention) | 20 | 6 | 1 | 1 | 28 |
The interpretation of preclinical studies | 19 | 7 | 3 | 29 | |
The use of placebo in controlled trials | 16 | 9 | 3 | 1 | 29 |
Assessment of understanding for informed consent | 16 | 10 | 1 | 1 | 28 |
Assessment of anticipated benefits | 15 | 8 | 5 | 1 | 29 |
Assessment of cultural sensitivity for informed consent | 15 | 9 | 3 | 1 | 28 |
Community participation | 14 | 11 | 3 | 1 | 29 |
Determination of appropriate subject selection in vulnerable population | 14 | 8 | 5 | 1 | 28 |
Determination of appropriate subject selection with regard to women | 13 | 6 | 8 | 1 | 28 |
Incentives for participation | 12 | 10 | 5 | 1 | 28 |
Social and behavioural studies | 12 | 10 | 6 | 1 | 29 |
Privacy and confidentiality | 11 | 13 | 4 | 1 | 29 |
Determination of appropriate subject selection with regard to minors | 11 | 9 | 6 | 1 | 27 |
*Some respondents did not answer some questions.